These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30976594)

  • 21. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-Year Experience in Treatment of Retinoblastoma with Intra-Arterial Chemotherapy: A Single-Center Analysis.
    Ghassemi F; Dehghani S; Mahmoudzadeh R; Khodabandeh A; Ghanaati H; Termehchi G
    J Curr Ophthalmol; 2021; 33(4):468-474. PubMed ID: 35128196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
    Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
    Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
    Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N
    Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Globe salvage treatment in group D and group E retinoblastoma.
    Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
    Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
    [No Abstract]   [Full Text] [Related]  

  • 26. Pushing the limit: Globe salvage of Group D retinoblastoma with severe vitreous seeding with intra-arterial chemotherapy and 15 cycles of intravitreal chemotherapy.
    Greig EC; Rabiee R; Afshar AR
    Am J Ophthalmol Case Rep; 2024 Mar; 33():101987. PubMed ID: 38283770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review.
    Wai YZ; Radhakrishnan DM; Lingam G; Hamzah N; Rahmat J
    Taiwan J Ophthalmol; 2023; 13(4):527-534. PubMed ID: 38249495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India.
    Rishi P; Agarwal A; Chatterjee P; Sharma T; Sharma M; Saravanan M; Ravikumar R
    Ocul Oncol Pathol; 2020 Jan; 6(1):66-73. PubMed ID: 32002408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
    De Francesco S; Galluzzi P; Bracco S; Menicacci F; Motolese E; Hadjistilianou T
    Int Ophthalmol; 2015 Dec; 35(6):887-95. PubMed ID: 26416040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
    Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
    Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
    Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Huang W; Jiang H; Xia J; Zhang S
    BMC Cancer; 2018 Apr; 18(1):486. PubMed ID: 29703164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
    Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.
    Abramson DH; Ji X; Francis JH; Catalanotti F; Brodie SE; Habib L
    Br J Ophthalmol; 2019 Apr; 103(4):488-493. PubMed ID: 29875233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study.
    Chen M; Jiang H; Zhang J; Shen G; Jiang Y; Li H; Liu Z
    Acta Ophthalmol; 2017 Sep; 95(6):613-618. PubMed ID: 27874261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review.
    Raval V; Bowen RC; Soto H; Singh A
    Ocul Oncol Pathol; 2021 Mar; 7(2):142-148. PubMed ID: 33981697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.